Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications
International Journal of Molecular Sciences · 01.04.2023 · 24 (7) · 6590
DOI: 10.3390/ijms24076590 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 01.04.2023. Verfasst von Mariacristina Gagliardi und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Enterprise for nanoScience and nanoTechnology (NEST), Nanoscience Institute-National Research Council (CNR) and Scuola Normale Superiore, Pi…. Hauptthemen laut MEDLINE: Chitosan, Nanoparticles. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Angelman Syndrome Alliance.
Abstract (Originalsprache)
Intranasal drug delivery is convenient and provides a high bioavailability but requires the use of mucoadhesive nanocarriers. Chitosan is a well-established polymer for mucoadhesive applications but can suffer from poor cytocompatibility and stability upon administration. In this work, we present a method to obtain stable and cytocompatible crosslinked chitosan nanoparticles. We used 2,6-pyridinedicarboxylic acid as a biocompatible crosslinker and compared the obtained particles with those prepared by ionotropic gelation using sodium tripolyphosphate. Nanoparticles were tested to evaluate the size and the surface charge, as well as their stability in storage conditions (4 °C), at the nasal cavity temperature (32 °C), and at the body temperature (37 °C). The crosslinked chitosan nanoparticles showed a size around 150 nm and a surface charge of 10.3 mV ± 0.9 mV, both compatible with the intranasal drug administration. Size and surface charge parameters did not significantly vary over time, indicating the good stability of these nanoparticles. We finally tested their cytocompatibility in vitro using SHSY5Y human neuroblastoma and RPMI 2650 human nasal epithelial cells, with positive results. In conclusion, the proposed synthetic system shows an interesting potential as a drug carrier for intranasal delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Enterprise for nanoScience and nanoTechnology (NEST), Nanoscience Institute-National Research Council (CNR) and Scuola Normale Superiore, Piazza San Silvestro 12, 56127 Pisa, Italy.
- Institute of Neuroscience, National Research Council (CNR), Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.
- Department of Developmental Neuroscience, Scientific Institute Stella Maris Foundation, Viale del Tirreno 331, Calambrone, 56128 Pisa, Italy.
ORCID-Profile: Mariacristina Gagliardi, Sara Chiarugi, Giulia Di Gregorio, Alessandra Diodati, Laura Baroncelli, Marco Cecchini, Ilaria Tonazzini
Förderung
- Angelman Syndrome Alliance
Zitieren
APA
Gagliardi, M., Chiarugi, S., De Cesari, C., Di Gregorio, G., Diodati, A., Baroncelli, L., Cecchini, M., & Tonazzini, I. (2023). Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications. International Journal of Molecular Sciences, 24(7), 6590. https://doi.org/10.3390/ijms24076590
Vancouver
Gagliardi M, Chiarugi S, De Cesari C, Di Gregorio G, Diodati A, Baroncelli L, et al. Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications. International Journal of Molecular Sciences. 2023;24(7):6590. doi:10.3390/ijms24076590
BibTeX
@article{Gagliardi2023,
author = {Gagliardi, Mariacristina and Chiarugi, Sara and De Cesari, Chiara and Di Gregorio, Giulia and Diodati, Alessandra and Baroncelli, Laura and Cecchini, Marco and Tonazzini, Ilaria},
title = {Crosslinked Chitosan Nanoparticles with Muco-Adhesive Potential for Intranasal Delivery Applications},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {7},
pages = {6590},
doi = {10.3390/ijms24076590}
}
EUVIMED